Physician profile

Robert A Lipman

Diagnostic Radiology · Honolulu, HI

NPI 1992878623

$1,578.66

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,242.14

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $297.60 2022-2023 Indigo System
Angiodynamics, INC. $282.52 2023 Alphavac, Nanoknife
Ethicon US, LLC $282.20 2023-2024 Certus 140, Neuwave
Terumo Medical Corporation $219.79 2022-2024 Azur Cx Detachable
Sirtex Medical INC $209.65 2024 Lava Les (Liquid Embolic System), Sir-Spheres Microspheres
Medtronic, INC. $105.71 2023 Abre
Bard Peripheral Vascular, INC. $98.09 2019
Teleflex LLC $83.10 2024 Arrow

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert A Lipman

$1,578.66

in general payments reported 2019-2025

Years
2019-2024
Top company
Penumbra, INC.

https://glasscript.com/doctor/932607/robert-a-lipman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.